GILD
Valuation Healthcare · Drug Manufacturers - General Data as of 2026-03-31P/E Ratio · Metrics
P/E Ratio
21.62
PEG Ratio
0.22
Dividend Yield
-
Gross Margin
79.24%
Net Margin
29.04%
Revenue CAGR 3Y
3.09%
ROE
34.38%
ROA
14.36%
Buyback Yield
-0.08%
Current Ratio
1.97
Magic Earn Yield
5.96%
Altman Z-Score
4.03
Fair Value River
Score
Valuation 63
Profitability 66
Growth 10
Health 73
Yield 0